Skip to main content
Login | Suomeksi | På svenska | In English

Browsing by Title

Sort by: Order: Results:

  • Paavilainen, Nea (2024)
    The eye is well-protected by several anatomical and physiological barriers which also pose significant challenges for ocular drug delivery. Even though ocular pharmacokinetics and the permeability of eye’s important anatomical barriers, such as the cornea and the blood-ocular barriers, have been thoroughly investigated, the significance of active transport in the eye is not completely understood. It is known that several drug transporters are also expressed in ocular tissues, but scientific information on this area is still dispersed and incomplete. The aim of the literature review in this master’s thesis was to compile the current knowledge on the expression and activity of OATP transporters (SLCO; organic anion transporting polypeptides) in cornea and in the blood-ocular barriers. Main principles of ocular pharmacokinetics and common methods for studying transporters are also discussed. The experimental part in this thesis is focused on retinal pigment epithelium (RPE) which is a substructure of the blood-retinal barrier. The transporters of the RPE were studied with three different RPE model systems: human RPE cell line (ARPE-19), fetal primary RPE cells (hfRPE; human fetal retinal pigment epithelium) and ocular tissues of the rabbit. In detail, transporter expression was studied with proteomics from the plasma membrane of isolated rabbit RPE and transporter activity by cellular uptake assays (ARPE-19, hfRPE) in vitro and permeability experiments with rabbit RPE-choroid-sclera ex vivo. As with the literature part, the experimental work was mainly focused on the human and rabbit OATP/Oatp transporters. In this thesis, ten important drug transporters were detected from the rabbit RPE. No significant OATP/Oatp activity was observed either in vitro or ex vivo experiments so these transporters seem not to have a great role in the disposition of their substrates in the studied RPE models. However, signs of other active transport were evident especially in the ARPE-19 cell line, in which significant accumulation of the tested substrate, 4’,5’-dibromofluorescein (DBF), was noted in the presence of several inhibitors. The phenomenon was suspected to result from efflux inhibition, but the responsible transporters could not be unequivocally detected. In conclusion, the findings of this thesis highlight the importance of conducting further research on the transporters of the RPE and choosing a suitable RPE model case-by-case for each study. With the compounds used in this thesis, ARPE-19 and hfRPE cells showed marked differences in efflux activity while the small size and fragile structure of the posterior ocular tissues of the rabbit caused notable difficulties in performing the transporter studies.
  • Randén, Sari (2024)
    Jätevedenpuhdistamon käsittelymenetelmät eivät poista kokonaan lääkeaineita jätevedestä. Lääkeainejäämiä jää käsiteltyyn jäteveteen ja siksi niitä löytyy pintavedestä. Vielä ei ole täysin selvää, miten altistuminen lääkeainejäämille vaikuttaa ihmisten terveyteen ja ympäristön hyvinvointiin. Tämän pro gradu -tutkielman tavoitteena oli ensin tunnistaa vesiympäristölle haitallisimmat lääkeaineet ja sen jälkeen selvittää, mitkä olivat haitallisimpien lääkeaineiden käyttömäärät HUSin hoitoyksiköissä vuonna 2021. Tutkimuksen tuloksia on tarkoitus hyödyntää jatkossa HUSissa, kun arvioidaan mahdollisia toimenpiteitä ympäristöriskien vähentämiseksi. Tässä tutkimuksessa ympäristöriskiä mahdollisesti aiheuttavien aineiden arviointi koski lääkeaineita, joita käytettiin ihmisten hoitoon vuonna 2021 Suomessa. Tutkimukseen otettiin mukaan ne lääkeaineet, joista oli saatavilla riittävästi dataa riskiosamäärän laskemiseksi (kun ei otettu huomioon lääkeaineen poistumaa jätevedenpuhdistamolla). Tutkimuksen ulkopuolelle rajattiin lääkeaineiden yhdistelmävalmisteet, eläinlääkkeet, vitamiinit, elektrolyytit, aminohapot, peptidit, proteiinit, hiilihydraatit, lipidit, kasvirohdosvalmisteet ja rokotteet. Riskiosamäärä laskettiin 521 lääkeaineelle. Lääkeaineiden, joiden riskiosamäärä oli suurempi kuin 1, katsottiin aiheuttavan riskiä vesiympäristössä: mitä suurempi oli aineelle laskettu riskiosamäärä, sitä suurempi oli ympäristöriski. 521 lääkeaineesta 39 lääkeaineen riskiosamäärä ylitti raja-arvon 1. Lääkeaineet, joiden riskiosamäärä oli yli 10, olivat ibuprofeeni, dabigatraanieteksilaatti, sulfasalatsiini, estradioli, lerkanidipiini, sertraliini, abirateroni, amoksisilliini, rifaksimiini ja vankomysiini. Näiden kymmenen vesiympäristölle haitallisimmin lääkeaineen kulutus vuonna 2021 HUSissa laskettiin hoitoyksiköittäin, jotta saatiin selville, missä hoitoyksiköissä käytettiin näitä lääkeaineita eniten. Kulutuksen laskennassa ei otettu huomioon hoitoyksiköiden jo olemassa olleita lääkevarastoja, jotka oli hankittu ennen vuotta 2021, eikä lääkehävikkiä (lääkejätettä). Tämän tutkimuksen perusteella puuttuva data oli merkittävin tulosten luotettavuuteen vaikuttava tekijä, koska ne lääkeaineet, joista ei ollut riittävästi dataa käytettävissä, jouduttiin rajaamaan tutkimuksen ulkopuolelle. Siten vesiympäristölle haitallisimpien lääkeaineiden luettelosta saattaa puuttua sinne kuuluvia lääkeaineita. Dataa olisi tarvittu etenkin lääkeaineiden poistumasta jätevedenpuhdistamolla sekä tutkimuksesta poisjääneiden lääkeaineiden kulutuksesta, teoreettisista vuorokausiannoksista ja ennustetuista vaikutuksettomista pitoisuuksista. Koska kaikkia haitallisimpia lääkeaineita ei ole vielä selvitetty, lisää tutkimusta ja työkaluja tarvitaan ongelman ratkaisemiseksi
  • Niemissalo, Sanna (2022)
    The aim of this master’s thesis was to investigate whether drug-induced inhibition of cytochrome P450 enzymes (CYP), especially time-dependent inhibition (TDI), could be the reason for bioaccumulation of the pharmaceuticals present in the aquatic environment in fish and whether the in vitro method could identify pharmaceuticals causing an environmental risk, which should primarily be investigated more closely. The half-maximal inhibitory concentrations (IC50) of seven antimicrobial drugs detected in the environment (erythromycin, clarithromycin, ketoconazole, clotrimazole, miconazole, ciprofloxacin, and sulfamethoxazole) and three known human time-dependent inhibitors (furafylline, diltiazem and verapamil) chosen for the validation of the method, were determined by EROD (7-ethoxy-resorufin-O-deethylase) and BFCOD (7-benzyloxy-4-trifluoromethyl-coumarin-O-debenzyloxylase) activities. The IC50 shift method and commercially available rainbow trout (Oncorhynchus mykiss) liver microsomes were used in determinations. The known human time-dependent inhibitors chosen for the validation of the method, furafylline (EROD) and diltiazem (BFCOD) proved to be possible time-dependent inhibitors also in rainbow trout in vitro, but this was not observed for verapamil (BFCOD). All antimicrobial drugs, except ciprofloxacin, inhibited more selectively BFCOD-reaction, as in human. In the case of sulfamethoxazole, inhibition was not observed at the concentrations used (0–500 µmol/L). Both enzyme activities (EROD and BFCOD) were inhibited in rainbow trout by ketoconazole, clotrimazole and miconazole. Among antimicrobial drugs acting as time-dependent inhibitors in human, erythromycin inhibited BFCOD activity in a time-dependent manner also in rainbow trout, but this was not observed for clarithromycin. Strongest inhibitors for CYP enzymes of rainbow trout in vitro were ketoconazole (EROD, IC50=4,19 µM and BFCOD, IC50=2,31 µM) and clotrimazole (EROD, IC50=33,78 µM and BFCOD, IC50=1,55 µM). The IC50 values of diltiazem, erythromycin, clarithromycin, ciprofloxacin, and verapamil were of the same order of magnitude as in human. The IC50 values of furafylline, ketoconazole, clotrimazole and miconazole were several times higher in rainbow trout than in human. Based on the results of this study, the IC50-shift method is also valid for fish, but there are differences in the inhibition potencies between human and fish, and the inhibition potency of human CYP enzymes cannot therefore directly predict enzyme inhibition of fish or the mechanism of inhibition. The In vitro measured IC50 values of rainbow trout were several orders of magnitude higher than the average concentrations of the pharmaceutical residues measured in the environment. Exposure to pharmaceutical mixtures is long-term, so interactions and bioaccumulation may still be possible due to inhibition of CYP enzymes. Developing a valid in vitro method for environmental risk assessment would be important, as animal experiments are ethically challenging.
  • Mulari, Perttu (2024)
    Cancer is a significant challenge for human health, causing approximately 9,6 million deaths annually. Critical problem in cancer treatments is chemoresistance, where cancer cells develop a resistance to the drugs used in the treatment. Chemoresistance has been studied for example with fluorescence spectroscopy and mass spectrometry. However, there are better options, as for example autofluorescence and photobleaching are a challenge in fluorescence spectroscopy and sample destruction in mass spectrometry. Vibrational spectroscopy is a label-free global method, which offers data extensively. The aim of this study is to evaluate the applicability of vibrational spectroscopy for studying chemoresistance using cisplatin sensitive TYK-nu cells and cisplatin resistant TYK-nu-CPR cells. Additionally, it is studied if there are difference on the spectra of a sample measured in liquid and dried. Infrared and Raman spectroscopy, which are used, are non-invasive and label free techniques that provide information about the biochemical structure of the samples. Techniques used in this study are infrared spectroscopy, Fourier transform Raman spectroscopy and confocal Raman spectroscopy. All techniques successfully distinguished the cell lines from each other according to the principal component analysis. Ratiometric analysis suggests a higher lipid to protein ratio in TYK-nu-CPR cells, which might be the separating factor between TYK-nu and TYK-nu-CPR cells. Liquid seemed to cause overlapping with peaks originating from the cell, and a large water related peak, which has to be taken into account if measuring cells in liquid.
  • Laakkonen, Laura (2024)
    Barcode-assisted medication administration can be used to prevent medication errors in pediatric hospital settings, as the medicine and the patient can be safely identified during the drug preparation and administration. The use of barcode-assisted medication administration has been examined in a few qualitative studies. In addition to the benefits, many challenges related to the implementation of this new workflow have been identified. The aim of this study was to identify facilitators and barriers related to the use of barcode-assisted medication administration in a children's hospital. The topic has not been studied in Finland before. A qualitative focus group study was carried out at HUS Helsinki University Hospital in the Department of Children and Adolescents. Ward pharmacists (n=14) were selected for the focus groups (n=3) by purposive sampling to identify persons using barcode-assisted medication administration on their daily work. Two researchers conducted the inductive content analysis independently, after which a consensus was formed first with these researchers and later with the entire research group. COREQ checklist was used to support detailed reporting and to consider the factors that might affect to the reliability of the study in each phase of the study. Four main themes were identified from the data; the barriers, the risk behavior caused by the barriers, the facilitators and the development ideas. The barriers included challenges related to negative attitudes of the end-users, barcodes on drug packages and labels, use of the electronic health record system, workstations and equipment, as well as orientation, competence and management. The barriers caused risk behavior that was related either to the system or to the end-user. On the other hand, the facilitators were associated with the positive experience of the end-user, the increase in expertise and multi-professional cooperation, the functions of the electronic health record system that supported the preparation and administration of the medicines, as well as the benefits of the barcode-assisted medication administration workflow. The development ideas aimed to remove the barriers and the risk behavior related to the use of barcode-assisted medication administration. The users found that the use of barcode-assisted medication administration increased patient and medication safety, although there were still many challenges associated with the new workflow. Barcode-assisted medication administration can be used to reduce medication errors and protect patients from adverse events. The results of this study can be used to develop the usability of barcode technology and their implementation.
  • Fant, Alexandra (2020)
    Many pharmacies sell medicines through digital online pharmacy services but studies have shown that only a small fraction of the population are aware of and are using these. There is a need to investigate online pharmacy services and the obstacles they are facing. What should be considered are e.g. the legislation online pharmacies operate under, how the health competency of the population is taken into account in the design of the services, the skills and attitudes of the professionals toward digitalization and distance communication as well as practical circumstances. The aim of this study is to examine the online pharmacy operators' perceptions of the services they provide and how they are organized in Finland and Sweden. How the national regulations that exist regarding online pharmacies, and especially regarding medicine counseling at online pharmacies, are implemented in practice are also examined. The study was targeted to all pharmacy actors in Finland (72) and Sweden (11) who offer online pharmacy services and have reported this to the authorities. Of these, 20 (28 %) responded in Finland and 4 (36 %) in Sweden. The study was designed as a survey consisting of closed/structured- and open-ended questions. The survey questions were developed from previous literature on the subject and a background analysis of the online pharmacies' web pages to ensure the baseline and the relevance of the questions. The survey was available to respondents in digital format and the link was distributed through e-mail in Winter 2020. Data from the closed-ended questions were compiled and analyzed using Microsoft Office Excel, while data from the open-ended questions were analyzed through qualitative content analysis. In Finland, only a small fraction of the total turnover of pharmacies comes from the online pharmacy business. Many believe in an increased importance of online pharmacies when younger age groups begin to use pharmacy services more frequently and technology enables more versatile solutions. In both countries, the main age group using online pharmacies were 36-45 years. The goods that were purchased were mainly cosmetics, skincare and non-prescription drugs. In Sweden, customers suffering of long-term illness were also reported to be a large customer group. As distance communication methods, telephone and e-mail were mostly offered, but in Sweden also chat. About half of the staff had received special communication training for distance communication. Many respondents stated being unaware of the fraction of customers asking for medication counseling and whether this counseling is appreciated. In most cases, the operators stated that the legislation on online pharmacy services was adequate. There are differences in the possibilities of operating online pharmacies in different markets. In Finland, the online pharmacy business's share of pharmacies' total sales is very limited. In Finland there is hope that online pharmacies will become more important to younger customer groups in the future and that the technology is developed to enable more versatile services. Operators in Finland believe that the services should be more beneficial to customers in the future. In both countries an increase in the sale of prescription medication is expected. Online pharmacies have great opportunities to offer customers versatile means of communication for medication counseling, but there is still a need to investigate employees' skills in distance communication. The counseling situation at online pharmacies should be evaluated to ensure equivalency with the one at physical pharmacies.
  • Äijö, Nelli (2019)
    As the population becomes older and the amount of multimorbid patients increases, also health care spending increases. New care models are needed where patients’ needs are taken into consideration by providing preventive and patient-centred care. In Finland and internationally, new ways to treat elderly, chronically ill patients have been developed. One of the new models is the health and care plan model. This longitudinal, randomised, controlled trial studied the health and care plan model’s impact on healthcare costs, patients’ physical functioning and patients’ quality of life. The aim of the study was to study the cost-effectiveness of the health and care plan model compared to standard care practice. The goal of this study was to study if rational pharmacotherapy and self-management support can prevent the decline in physical functioning, the decline in quality of life and the increase in health service use and costs among elderly population. This study was conducted between 2014-2018 as a multi-disciplinary cooperation between Tornio health station, University of Helsinki Faculty of Pharmacy and Alatornio pharmacy. The patients in this study were over 75-year old, multimorbid, community dwelling, polypharmacy patients. The patients in the intervention group received an interview based clinical medication review and were formed a medication plan. Furthermore, the patients in the intervention group were planned a health and care plan that was combined with the medication plan into a comprehensive self-management plan in a multi-disciplinary meeting. A case manager was appointed for the patients in the intervention group and the case manager could be contacted by the patients in the intervention group at any point of the study if there arose a non-acute concern with the patient’s health. The patients in the control group were conducted a prescription review based on the information available in the electronic health records system and continued receiving the standard care practice. Cost and effectiveness data were gathered from the patients over the period of two years. The effectiveness data were gathered at Tornio health station where the intervention and control group’s quality of life was measured with the SF-36 generic quality of life measure and physical functioning was measured with Short Physical Performance Battery (SPPB). The quality of life data gathered with SF-36 were transformed into one preference based single index score SF-6D to calculate the quality of life and quality adjusted life years (QALY). Data about the use of health services were extracted from the electronic health records system and transformed into costs by using the national reference costs. At the beginning of the study, the intervention and control group were statistically significantly similar. During the two-year follow-up, no statistically or clinically significant differences were observed between the intervention and control group in their quality of life, in their physical functioning or in the costs of used health services. However, in the intervention group, the cost of used health services was on average 2 406 euros smaller than those of the control group’s during the two-year follow-up. The health and care plan model was cost-effective compared to standard care practice. The incremental cost-effectiveness ratio was -64 504 € per one QALY. Based on this study, it is recommended to support the self-management and physical functioning of the elderly with an intervention like health and care plan model to decrease the health care spending. The results of this study can be applied to Finnish healthcare system to decrease the health care spending of multimorbid, community dwelling and polypharmacy elderly patients. The use of real-world evidence increases the reliability of this study.
  • Valle, Jenni (2018)
    Gut inflammation and permeability is speculated to play a major role in the pathophysiology of several human diseases. Signs of a low-grade gut inflammation in patients with type 1 diabetes (T1D) have been found. Focus of this study was to understand the role of gut inflammation and increased gut permeability in the development of diabetic complications, especially nephropathy. Approximately, one-third of Finnish patients with T1D develop kidney disease during their lifetime. Inflammatory mechanisms may have an essential role in the pathophysiology of the disease. Lipopolysaccharide, LPS, is found in the outer membrane of gram-negative bacteria. LPS activates innate immune system and triggers the activation of inflammatory cytokines, neutrophils and macrophages as well as many pathophysiological processes in vivo, for instance fever and endotoxic shock. Aim of this study was to establish a zebrafish gut inflammation model using fluorophore conjugated endotoxin, LPS. We hypothesized that delivery of LPS in addition to EDTA in the gut of zebrafish triggers inflammation and increased gut permeability which may lead to leakage of LPS to blood stream and potentially kidney injury. This novel zebrafish inflammation model could possibly be used for studying the pathophysiological mechanisms of gut inflammation and possible kidney injury as well as for screening new anti-inflammatory drugs. In addition, this animal model can be used for studying intestinal alkaline phosphatase (IAP) in reducing gut permeability and LPS-mediated kidney damage. IAP is an enzyme produced in small-intestinal epithelium. IAP can detoxify several bacterial endotoxins including LPS and thus protect against the induction of intestinal inflammation. LPS and EDTA were delivered in the gut of 6 days old zebrafish larvae using microgavage injection. Fluorescence microscopy imaging of live zebrafish enabled following the same individual at different timepoints after injections. Paraffin sectioning of the small larvae was promising for investigating the morphology and permeability of the gut as well as possible immunostaining for detection of IAP. L-phenylalanine was used for inhibition of IAP enzyme. Using the novel method of microinjection to gut on zebrafish larvae the timing and amount of delivered materials to gut can be controlled well. The anatomy and function of the gut in zebrafish is very similar to small intestine of mammals and the highly developed vertebrate immune system makes zebrafish an interesting model organism for studying gut inflammation and permeability. In addition, inflammatory processes can be visualized in live, intact transparent zebrafish larvae. However, the technique has a lot of challenges including small size of the fish and possible tissue damage of the fish while performing injection. More experiments need to be carried out to establish the model for drug screening. Also, along with microscopy images, a more precise way for quantification the gut permeability is needed. Based on the images it’s not yet possible to conclude whether LPS increased gut permeability or if IAP inhibition with L-phenylalanine worked in zebrafish larvae. Using adult zebrafish in the future will give more information about the chronic gut inflammation and development of possible kidney injury.
  • Yli-Rantala, Anni (2014)
    Zebrafish (Danio rerio) is a vertebrate model organism. It is suited for many phases of drug development process like toxicological studies. The major advantage of using zebrafish is the possibility to conduct high-throughput screens on a whole vertebrate animal. However, there is not as much knowledge about zebrafish as there is about other model organisms. Therefore there might be differences between zebrafish and humans that affect the use of zebrafish as a model in the drug development process. The purpose of this thesis was to characterize the structure of the zebrafish oxytocin system and assess the role of oxytocin on zebrafish behaviour. In humans defects in the oxytocin system have been linked to many psychiatric disorders like autism. If the mammalian and zebrafish oxytocin systems resembled each other functionally and structurally, it would enable the use of zebrafish as a model when studying the role of oxytocin in pathophysiology of diseases and also in oxytocin system related drug development. The structure and development of zebrafish oxytocin system was studied by staining adult zebrafish brain cryosections and larval brains with antibodies made against mammalian oxytocin. The specificity of the antibodies to recognize zebrafish oxytocin was determined by absorption and cross-reactivity controls. The role of oxytocin on zebrafish locomotion was studied by inhibiting the splicing of oxytocin messenger RNA with morpholino oligonucleotides (MOs). The MOs were used to address the relevance of the model in pharmacology, since the zebrafish oxytocin receptors have not been expressed and pharmacologically characterized. In zebrafish oxytocin was produced in the cells of the preoptic nucleus. There were thick oxytocin fibers towards the pituitary and also thinner fibers into areas in the telencephalon, diencephalon, mesencephalon and rhombencephalon. One of the MOs was able to inhibit the production of oxytocin with a dose that did not cause morphological abnormalities. The MO reduced the locomotor activity of the fish, but the specificity of the MO has to be determined. The structure of the zebrafish oxytocin system resembles mammalian oxytocin system in terms of the location of oxytocin cells and fiber projections. Therefore zebrafish seems a suitable model organism for oxytocin research. However, the structure of the zebrafish oxytocin receptor system and the effect of oxytocin on other behavioural aspects have to be determined in order to further evaluate the applicability of zebrafish for oxytocin research.
  • Tapanainen, Tuukka (2017)
    The α5 subunit of nicotinic acetylcholine receptors forms functional receptors with other subunits as a structural subunit. It affects the structural and functional properties of the nicotinic receptor by increasing calcium permeability and accelerating desensitization. In the mammalian brain, the α5 mRNA is widely expressed, mostly in substantia nigra pars compacta, ventral tegmental area and interpeduncular nucleus. Its protein has been identified in various distinct brain areas, such as striatum, cortex and medial habenula. In the dorsal striatum partaking in motor functions, the α5 subunit modulates the release of dopamine, thus it is believed to have an impact on motor function. In the experimental part of the thesis mice lacking the α5 subunit were injected unilaterally with neurotoxin 6-hydroxydopamine (6-OHDA) in the striatum. The purpose was to determine the importance of the subunit with regard to the lesion extent and motor function. The motor functions of α5-deficient and wild type control mice were assessed in amphetamine- and apomorphine-induced rotametry. After the tests the mice were euthanized and their substantia nigra and striatal brain samples were collected for further analysis. The number of dopamine cells in the medial and dorsal tier of substantia nigra were determined, so as to quantify the extent of the lesions and to explain the research group's previous finding about the α5-deficient mice spinning less ipsilaterally in amphetamine induced rotametry. The α5-deficient mice were found to turn less ipsilaterally compared to the control mice in the amphetamine-induced rotametry and in the apomorphine-induced rotametry, first less contralaterally and subsequently more contralaterally than the control mice. The results of male mice, that were less in number, were excluded from the results as the difference between genders was significant in the wild type mice in the amphetamine-induced rotametry. There was no significant difference in the number of remaining dopamine cells between the genotypes after the lesioning in either of the areas of interest. However, the wild type mice tended to have less cells remaining in the medial tier of the substantia nigra. The observed differences between the genotypes in the rotametries could be accounted by differences in the amount of dopamine released from striatal neurons or differences in striatal dopamine receptor quantities or function. The results support the hypothesis about the contribution of the α5 subunit containing acetylcholine nicotinic receptors in motor function.
  • Pätsi, Sauli (2013)
    Parkinson's disease is a neurodegenerative disease which is characterized by progressive loss of dopaminergic neurons in the substantia nigra and formation of intracellular Lewy bodies. α-synuclein is an essential part of Lewy bodies. In addition, mutations in the α-synuclein gene have been found to cause rare familial forms of Parkinson's disease. Animal models of Parkinson's disease are created by neurotoxins, transgenic animals and viral vectors. Transgenic animal models and viral vector models seem to reflect the pathology of Parkinson's disease better than the traditional neurotoxin models. In the transgenic animal models, the transgene and the promoter used in the expression of the transgene guide the pathology and motor dysfunctions that the animal model exhibits. In the viral vector models, it is important to use a suitable animal strain and a correct viral serotype in order to express the transgene sufficiently enough in the laboratory animals. The aim of the study was to investigate the ability of adeno-associated viral vector (AAV1-vector) to transfect WT- or A53T-α-synuclein gene into the striatum or the substantia nigra, and the effects of their overexpression on motor functions and concentrations of striatal dopamine and its metabolites in mice. In addition, the effect of a prolyl endopeptidase (PREP) inhibitor on the overexpression of A53T-α-synuclein in the mouse nigrostriatal pathway was studied, as PREP has been found to stimulate the aggregation of α-synuclein and therefore perhaps to increase neurotoxicity of α-synuclein. There were no statistically significant differences between the groups in the motor function tests (locomotor activity, rotarod and balance beam walk). Green fluorescent protein immunostaining showed that the GFP gene was weakly transfected into the striatum by the AAV1-vector, and no overexpression was observed. There were only minor differences in the striatal concentrations of dopamine and its metabolites. Finally, PREP-activity measurements showed that PREP-inhibitor (KYP-2047) treatment had poorly reduced PREP-activity. In this study, the viral vectors did not induce the overexpression of α-synuclein, although previously AAV2- and AAV6-vectors have been efficient in mice and rats. High PREP-activities that were found in most of the samples probably resulted from failed installations of mini-pumps that delivered the PREP-inhibitor. While in this study the viral vectors were not a successful attempt in the creation of an animal model of Parkinson's disease, they are an important method to model Parkinson's disease in the future.
  • Eteläinen, Tony (2017)
    lcohol addiction is a significant public health problem worldwide, and its treatment is extremely challenging. One major problem in the treatment of alcohol addiction are the later relapses to uncontrollable drinking. Approximately 60-70 % of addicts relapse to drinking within a year from the beginning of the treatment. The current treatment of alcohol addiction is based on a combined psychotheraphy and pharmacological treatments, but even at the best the efficacy remains quite modest. This is why further studies on the underlying mechanisms behind alcohol addiction and development of more effective pharmaceuticals to treat it are an important field of research. Chronic exposure to the rewarding effects of alcohol causes neurochemical adaptations in the brain reward system. These adaptations strive to restrain the recurring rewarding signals caused by alcohol and lead eventually to increased reward thresholds in the reward system. As the reward thresholds increase, the individual develops tolerance to the rewarding effects of alcohol, but also craving for the substance and a dysphoric mental state which are highlighted especially during periods of abstinence. It is known that the increase in reward thresholds is an important factor leading to relapses, but the exact nature of the neurochemical adaptations behind it are not known. According to recent studies dynorphin -peptides (DYN) and κ-opioid receptors (KOR) of the endogenous opioid system seem to have an important role in these neurochemical adaptations. It has been shown that chronic alcohol exposure increases the activity of DYN/ KOR -system especially within the nucleus accumbens (NAc), which is an essential structure of the brain reward system. The increased activity of the DYN/ KOR -system in the NAc has been shown to inhibit the development of rewarding signals. Previous studies have shown that inhibiting the increased activity of the DYN/ KOR -system with a selective KOR-antagonist, reduces voluntary alcohol intake and relapse-like alcohol seeking behavior during periods of abstinence, especially in physically addicted animals. In this study we studied the relapse-like alcohol drinking of Long-Evans rats in the alcohol deprivation effect (ADE) model. The effects of selective and long-acting KOR-antagonists, JDTic and nor-BNI, were tested on the ADE-effect which occurs after a period of deprivation. The ADE is defined as a transient increase in alcohol intake after a forced period of abstinence and it has been shown both in rodents with a history of alcohol consumption, and human alcohol addicts. In this study the rats were allowed to consume alcohol (10% ethanol-water solution) voluntarily during 90 minutes for 10 consecutive days after which followed a six days long deprivation period. According to results, both intra-accumbally (15 µg/ 0,3 µl/min/ site) or subcutaneously (10 mg/kg) administered JDTic decreased the ADEeffect significantly compared to vehicle, when administered 24 hours prior the end of the deprivation period. Also intra-accumbally administered nor-BNI (3 µg/0,3 µl/min/site) decreased the ADE-effect significantly compared to vehicle when administered 24 hour prior the end of deprivation. The results are in line with the theory that alcohol induces sensitization of the DYN/ KOR -system within the brain structures involved in reward. In theory it can be speculated that by suppressing the activity of the DYN/ KOR -system, KOR-antagonists can relieve craving for alcohol. This can be seen as a decrease in relapse-like consumption of alcohol. In conclusion, it can be suggested that by suppressing the increased activity of the DYN/ KOR -system induced by chronic alcohol exposure with a selective KOR-antagonist, like JDTic or nor-BNI, it could be possible to reduce the risk of relapse during abstinence and thus improve the efficacy of treatments for alcohol addiction.